502 related articles for article (PubMed ID: 31501983)
21. Pretreatment elevated fibrinogen level predicts worse oncologic outcomes in upper tract urothelial carcinoma.
Xu H; Ai JZ; Tan P; Lin TH; Jin X; Gong LN; Lei HR; Yang L; Wei Q
Asian J Androl; 2020; 22(2):177-183. PubMed ID: 31169138
[TBL] [Abstract][Full Text] [Related]
22. Oncologic outcomes for open and laparoscopic radical nephroureterectomy in patients with upper tract urothelial carcinoma.
Kido K; Hatakeyama S; Fujita N; Yamamoto H; Tobisawa Y; Yoneyama T; Yoneyama T; Hashimoto Y; Koie T; Iwabuchi I; Ogasawara M; Kawaguchi T; Ohyama C
Int J Clin Oncol; 2018 Aug; 23(4):726-733. PubMed ID: 29435873
[TBL] [Abstract][Full Text] [Related]
23. Effect of lymph node dissection on stage-specific survival in patients with upper urinary tract urothelial carcinoma treated with nephroureterectomy.
Zhai TS; Jin L; Zhou Z; Liu X; Liu H; Chen W; Lu JY; Yao XD; Feng LM; Ye L
BMC Cancer; 2019 Dec; 19(1):1207. PubMed ID: 31830927
[TBL] [Abstract][Full Text] [Related]
24. Prognostic role of lymphovascular invasion in patients with urothelial carcinoma of the upper urinary tract: an international validation study.
Novara G; Matsumoto K; Kassouf W; Walton TJ; Fritsche HM; Bastian PJ; Martínez-Salamanca JI; Seitz C; Lemberger RJ; Burger M; El-Hakim A; Baba S; Martignoni G; Gupta A; Karakiewicz PI; Ficarra V; Shariat SF
Eur Urol; 2010 Jun; 57(6):1064-71. PubMed ID: 20071073
[TBL] [Abstract][Full Text] [Related]
25. Extraurothelial recurrence after radical nephroureterectomy: preoperative predictors and survival.
Dzamic Z; Milojevic B; Kajmakovic B; Grozdic Milojevic I; Bojanic N; Sipetic Grujicic S
Int Urol Nephrol; 2015 May; 47(5):775-9. PubMed ID: 25772384
[TBL] [Abstract][Full Text] [Related]
26. Outcomes of radical nephroureterectomy: a series from the Upper Tract Urothelial Carcinoma Collaboration.
Margulis V; Shariat SF; Matin SF; Kamat AM; Zigeuner R; Kikuchi E; Lotan Y; Weizer A; Raman JD; Wood CG;
Cancer; 2009 Mar; 115(6):1224-33. PubMed ID: 19156917
[TBL] [Abstract][Full Text] [Related]
27. Prospective analysis of Ki-67 as an independent predictor of oncologic outcomes in patients with high grade upper tract urothelial carcinoma.
Krabbe LM; Bagrodia A; Lotan Y; Gayed BA; Darwish OM; Youssef RF; John G; Harrow B; Jacobs C; Gaitonde M; Sagalowsky AI; Shariat SF; Kapur P; Margulis V
J Urol; 2014 Jan; 191(1):28-34. PubMed ID: 23871758
[TBL] [Abstract][Full Text] [Related]
28. The Systemic Immune-Inflammation Index (SII) Increases the Prognostic Significance of Lymphovascular Invasion in Upper Tract Urothelial Carcinoma After Radical Nephroureterectomy.
Jan HC; Wu KY; Tai TY; Weng HY; Yang WH; Ou CH; Hu CY
Cancer Manag Res; 2022; 14():3139-3149. PubMed ID: 36386553
[TBL] [Abstract][Full Text] [Related]
29. Efficacy of post-nephroureterectomy cisplatin-based adjuvant chemotherapy for locally advanced upper tract urothelial carcinoma: a multi-institutional retrospective study.
Nakagawa T; Komemushi Y; Kawai T; Otsuka M; Miyakawa J; Uemura Y; Kanatani A; Taguchi S; Naito A; Suzuki M; Nishimatsu H; Hirano Y; Tanaka Y; Matsumoto A; Miyazaki H; Fujimura T; Fukuhara H; Kume H; Igawa Y; Homma Y
World J Urol; 2017 Oct; 35(10):1569-1575. PubMed ID: 28397000
[TBL] [Abstract][Full Text] [Related]
30. Variant histology as a significant predictor of survival after radical nephroureterectomy in patients with upper urinary tract urothelial carcinoma.
Kim JK; Moon KC; Jeong CW; Kwak C; Kim HH; Ku JH
Urol Oncol; 2017 Jul; 35(7):458.e9-458.e15. PubMed ID: 28347659
[TBL] [Abstract][Full Text] [Related]
31. Radical nephroureterectomy for pathologic T4 upper tract urothelial cancer: can oncologic outcomes be improved with multimodality therapy?
Youssef RF; Lotan Y; Sagalowsky AI; Shariat SF; Wood CG; Raman JD; Langner C; Zigeuner R; Roscigno M; Montorsi F; Bolenz C; Kassouf W; Margulis V
Int Braz J Urol; 2013; 39(5):614-21. PubMed ID: 24267122
[TBL] [Abstract][Full Text] [Related]
32. TALL score for prediction of oncological outcomes after radical nephroureterectomy for high-grade upper tract urothelial carcinoma.
Youssef RF; Krabbe LM; Shariat SF; Lotan Y; Sagalowsky AI; Raman J; Wood CG; Weizer A; Roscigno M; Montorsi F; Bolenz C; Remzi M; Bensalah K; Kassouf W; Margulis V
World J Urol; 2015 Dec; 33(12):1965-72. PubMed ID: 25957592
[TBL] [Abstract][Full Text] [Related]
33. Prognostic significance of non-muscle-invasive bladder tumor history in patients with upper urinary tract urothelial carcinoma.
Milojevic B; Djokic M; Sipetic-Grujicic S; Grozdic Milojevic I; Vuksanovic A; Nikic P; Vukovic I; Djordjevic D; Bumbasirevic U; Tulic C
Urol Oncol; 2013 Nov; 31(8):1615-20. PubMed ID: 22521771
[TBL] [Abstract][Full Text] [Related]
34. Prognostic value of lymph node yield during nephroureterectomy for upper tract urothelial carcinoma.
Winer AG; Vertosick EA; Ghanaat M; Corradi RB; Carlsson S; Sjoberg DD; Sankin AI; Sfakianos JP; Cha EK; Dalbagni G; Coleman JA
Urol Oncol; 2017 Apr; 35(4):151.e9-151.e15. PubMed ID: 27932270
[TBL] [Abstract][Full Text] [Related]
35. Prognostic Value of Lymphovascular Invasion in Upper Urinary Tract Urothelial Carcinoma after Radical Nephroureterectomy: A Systematic Review and Meta-Analysis.
Liu W; Sun L; Guan F; Wang F; Zhang G
Dis Markers; 2019; 2019():7386140. PubMed ID: 31565103
[TBL] [Abstract][Full Text] [Related]
36. Prognostic significance of tumor multifocality on outcomes in patients with upper tract urothelial carcinoma after radical nephroureterectomy: A cohort study.
Milojevic B; Bumbasirevic U; Santric V; Kajmakovic B; Dragicevic D; Radisavcevic D; Sretenovic M; Grujicic SS
Curr Probl Cancer; 2021 Dec; 45(6):100747. PubMed ID: 33883080
[TBL] [Abstract][Full Text] [Related]
37. Role of adjuvant chemotherapy for lymph node-positive upper tract urothelial carcinoma and the prognostic significance of C-reactive protein: A multi-institutional, retrospective study.
Fujita K; Inamoto T; Yamamoto Y; Tanigawa G; Nakayama M; Mori N; Tsujihata M; Azuma H; Nonomura N; Uemura M
Int J Urol; 2015 Nov; 22(11):1006-12. PubMed ID: 26153093
[TBL] [Abstract][Full Text] [Related]
38. The impact of lymphovascular invasion in patients treated with radical nephroureterectomy for upper tract urothelial carcinoma: An extensive updated systematic review and meta-analysis.
Stangl-Kremser J; Muto G; Grosso AA; Briganti A; Comperat E; Di Maida F; Montironi R; Remzi M; Pradere B; Soria F; Albisinni S; Roupret M; Shariat SF; Minervini A; Teoh JY; Moschini M; Cimadamore A; Mari A;
Urol Oncol; 2022 Jun; 40(6):243-261. PubMed ID: 35241364
[TBL] [Abstract][Full Text] [Related]
39. Selected High-Risk Patients With Upper Tract Urothelial Carcinoma Treated With Radical Nephroureterectomy for Adjuvant Chemotherapy: A Multi-Institutional Retrospective Study.
Ikeda M; Matsumoto K; Hirayama T; Koguchi D; Murakami Y; Matsuda D; Okuno N; Utsunomiya T; Taoka Y; Irie A; Iwamura M
Clin Genitourin Cancer; 2018 Jun; 16(3):e669-e675. PubMed ID: 29239844
[TBL] [Abstract][Full Text] [Related]
40. The characteristics of recurrent upper tract urothelial carcinoma after radical nephroureterectomy without bladder cuff excision.
Kang M; Jeong CW; Kwak C; Kim HH; Ku JH
Yonsei Med J; 2015 Mar; 56(2):375-81. PubMed ID: 25683984
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
